Supernus Pharmaceuticals Inc
SWB:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
S
|
Sartorius AG
XBER:SRT
|
DE |
|
H
|
Hyundai Motor Co
KRX:005385
|
KR |
|
Canada Nickel Company Inc
XTSX:CNC
|
CA |
|
C
|
Constellation Brands Inc
XMUN:CB1A
|
US |
|
AdvanSix Inc
F:960
|
US |
Wall St Price Targets
S49 Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for S49 is 54.43 EUR with a low forecast of 46.93 EUR and a high forecast of 58.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S49's stock price target?
Price Target
54.43
EUR
According to Wall Street analysts, the average 1-year price target for S49 is 54.43 EUR with a low forecast of 46.93 EUR and a high forecast of 58.55 EUR.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 63%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 8 years is 62%.
